Log In
BCIQ
Print this Print this
 

CT-112

  Manage Alerts
Collapse Summary General Information
Company Nuo Therapeutics Inc.
DescriptionPlatelet factor 4 derived octapeptide sequence TTSQVRPR
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard Indication Inflammation (unspecified)
Indication DetailsTreat inflammatory diseases
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today